Optimization of artificial neural networks for modeling of atorvastatin and its impurities retention in micellar liquid chromatography

Chromatographia

Volumn 73, Issue 9-10, 2011, Pages 993-998

  Malenović, Andelija ^a   Jancic Stojanovic, Biljana ^a   Kostić, Nada ^a   Ivanović, Darko ^a   Medenica, Mirjana ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Artificial neural networks; Atorvastatin; Impurities; Micellar liquid chromatography; Network's optimization

Indexed keywords

ATORVASTATIN;

ALGORITHM; ARTICLE; ARTIFICIAL NEURAL NETWORK; BACK PROPAGATION; DRUG IMPURITY; DRUG STRUCTURE; MICELLAR LIQUID CHROMATOGRAPHY; PREDICTION; PRIORITY JOURNAL; REACTION OPTIMIZATION;

EID: 79958250797     PISSN: 00095893     EISSN: 16121112     Source Type: Journal    
DOI: 10.1007/s10337-011-1994-6     Document Type: Article

References (35)

1. Jančić-Stojanović B, Ivanović D, Malenović A, Medenica M (2009) Talanta 78:107-112
2. Jančić B, Medenica M, Ivanović D, Janković S, Malenović A (2008) J Chromatogr A 1189:366-373
3. Jančić B, Medenica M, Ivanović D, Malenović A, Popović I (2008) Chromatographia 67:S123-S127
4. Hameda AB, Elosta S, Havel J (2005) J Chromatogr A 1084:7-12
5. Novotná K, Havliš J, Havel J (2005) J Chromatogr A 1096:50-57
6. Marengo E, Gianotti V, Angioi S, Gennaro MC (2004) J Chromatogr A 1029:57-65
7. Tran ATK, Hyne RV, Pablo F, Day WR, Doble P (2007) Talanta 71:1268-1275
8. Havel J, Madden JE, Haddad PR (1999) Chromatographia 49:481-488
9. Wang H, Liu W (2004) J Sep Sci 27:1189-1194
10. Bolanča T, Cerjan-Stefanović Š, Novič M (2005) Chromatographia 61:181-187
11. Bolanča T, Cerjan-Stefanović Š, Regelja M, Regelja H, Lončarić S (2005) J Chromatogr A 1085:74-85
12. Bolanča T, Cerjan-Stefanović Š, Ukić Š, Luša M, Rogošić M (2009) Chromatographia 70:15-20
13. Srečnik G, Debeljak Ž, Cerjan-Stefanović Š, Bolanča T, Novič M, Lazarić K, Gumhalter-Lulić Ž (2002) Croat Chem Acta 75:713-725
14. Vasiljević T, Onjia A, Čokeša Crossed D sign, Laušević M (2004) Talanta 64:785-790
15. Hervás C, Martinez AC, Silva M, Serrano JM (2005) J Chem Inf Model 45:894-903
16. Arulsudar N, Subramanian N, Murthy RSR (2005) J Pharm Pharmaceut Sci 8:243-258
17. Takayama K, Fujikawa M, Nagai T (1999) Pharm Res 16:1-6
18. Murtoniemi E, Merkku P, Kinnunen P, Leiviska K, Yliruusi J (1994) Int J Pharm 110:101-108
19. Tham SY, Agatonović-Kuštrin S (2002) J Pharm Biomed Anal 28:581-590
20. Ruggieri F, D'Archivio AA, Carlucci G, Mazzeo P (2005) J Chromatogr A 1076:163-169
21. Loukas YL (2000) J Chromatogr A 904:119-129
22. So SS, Karplus M (1996) J Med Chem 39:5246-5256
23. So SS, Richards WG (1992) J Med Chem 35:3201-3207
24. Loukas YL (2001) Int J Pharm 226:207-211
25. Erturk S, Sevinc Aktas E, Ersoy L, Ficicioglu S (2003) J Pharm Biomed Anal 33:1017-1023
26. Petkovska R, Cornett C, Dimitrovska A (2008) Anal Lett 41:992-1009
27. Nigović B, Damić M, Injac R, Kočevar Glavač N, Štrukelj B (2009) Chromatographia 69:1299-1305
28. Ferreiera SLC, Bruns RE, Da Silva EGP, Dos Santos WNL, Quintella CM, David JM, De Andrade JB, Breitkreitz MC, Jardim ICSF, Neto BB (2007) J Chromatogr A 1158:2-14
29. Myers RH, Montgomery DC (2002) Response surface methodology: process and product optimization using designed experiments. Wiley, New York
30. Malenović A, Ivanović D, Medenica M, Jančić B, Marković S (2004) J Sep Sci 27:1087-1092
31. Jančić-Stojanović B, Malenović A, Ivanović D, Rakić T, Medenica M (2009) J Chromatogr A 1216:1263-1269
32. Jančić-Stojanović B, Malenović A, Ivanović D, Medenica M (2009) Acta Chim Slov 56:507-512
33. Armstrong NA (2006) Pharmaceutical experimental design and interpretation. Taylor & Francis, London
34. Cybenko G (1989) Mathematics of control signals and systems - MCSS 2:303-314
35. Bishop CM (1995) Neural networks for pattern recognition. University press, Oxford